Piotr Wiland

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

H.W. van Steenbergen, Daniel Aletaha, Liesbeth J J Beaart-van de Voorde et al. · Annals of the Rheumatic Diseases · 2016 · 312 citations · Full text

Medicine, Internal Medicine, Autoimmunity +11

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

Dae‐Hyun Yoo, Nenad Prodanović, Janusz Jaworski et al. · Annals of the Rheumatic Diseases · 2016 · 280 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Won Park, Dae‐Hyun Yoo, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2016 · 229 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatment

Maria Ziółkowska, Anna Radzikowska, Grazyna Luszczykiewicz et al. · Arthritis & Rheumatism · 2002 · 200 citations

Life Sciences, Immunology, Orthopedic Surgery +17

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

Frank Behrens, Paul P. Tak, Mikkel Østergaard et al. · Annals of the Rheumatic Diseases · 2014 · 151 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14